Limertinib
Limertinib (ASK120067) is an oral, potent, and selective EGFR tyrosine kinase inhibitor designed to target the T790M resistance mutation. It is a valuable research tool for investigating non-small cell lung cancer (NSCLC) in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
1934259-00-3
Product Name Alternative
ASK120067, ASK-120067, ASK 120067
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.44% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (3.66 mM) ; DMSO:40 mg/mL (73.25 mM)
Smiles
O=C (C=C) NC1=CC (NC2=NC=C (Cl) C (=N2) NC=3C=CC=4C=CC=CC4C3) =C (OC) C=C1N (C) CCN (C) C
Molecular Formula
C29H32ClN7O2
Molecular Weight
546.06
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
25021061 1.0 µg DNA
INVS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details